Efficacy News and Research

RSS
Altheus Therapeutics receives patent for oral combination therapy for treating inflammatory bowel disease

Altheus Therapeutics receives patent for oral combination therapy for treating inflammatory bowel disease

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

Omeros announces positive results from Phase 2a trial of OMS824 in patients with schizophrenia

EORTC study evaluates health-related quality of life assessment in small-cell lung cancer

EORTC study evaluates health-related quality of life assessment in small-cell lung cancer

Transgenic mouse model validates mutant IDH2 protein as candidate for targeted anticancer therapies

Transgenic mouse model validates mutant IDH2 protein as candidate for targeted anticancer therapies

Cell Therapeutics completes patient enrollment in Phase 3 clinical trial of Opaxio in ovarian cancer

Cell Therapeutics completes patient enrollment in Phase 3 clinical trial of Opaxio in ovarian cancer

Seward highlights effectiveness of Stomacher technique and sponge swabs for hygiene monitoring

Seward highlights effectiveness of Stomacher technique and sponge swabs for hygiene monitoring

Top-line results from two Phase 3 studies of dacomitinib for patients with advanced NSCLC published

Top-line results from two Phase 3 studies of dacomitinib for patients with advanced NSCLC published

S. pneumoniae predicts acute sinusitis microbial response

S. pneumoniae predicts acute sinusitis microbial response

South Korean lung SCC genetic secrets revealed

South Korean lung SCC genetic secrets revealed

ABIHM expands to become the Academy of Integrative Health & Medicine

ABIHM expands to become the Academy of Integrative Health & Medicine

Copenhagen researchers boost self-efficacy of diabetic patients through motivational health coaching

Copenhagen researchers boost self-efficacy of diabetic patients through motivational health coaching

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

First patient enrolled pilot clinical trial of NovoTTF Therapy plus gemcitabine for pancreatic adenocarcinoma

Scientists identify genetic alterations in pediatric soft-tissue cancer

Scientists identify genetic alterations in pediatric soft-tissue cancer

FDA to make recommendations on safety of oral tablets used to treat ragweed allergy symptoms

FDA to make recommendations on safety of oral tablets used to treat ragweed allergy symptoms

Aspirin intake correlates with halted growth of lethal intracranial tumor

Aspirin intake correlates with halted growth of lethal intracranial tumor

Early onset of dietary treatment may slow down progression of Alzheimer's disease

Early onset of dietary treatment may slow down progression of Alzheimer's disease

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

TherapeuticsMD starts TX 12-002-HR phase 3 clinical trial for secondary amenorrhea

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Bristol-Myers Squibb fourth quarter 2013 revenues increase 6% to $4.4 billion

Researchers suggest effective ways to mitigate drinking problems among new students in colleges

Researchers suggest effective ways to mitigate drinking problems among new students in colleges

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.